Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center (Q38052332)

27 August 2017

Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center (English)

1 reference

27 August 2017

1 reference

M R Abern

1

1 reference

27 August 2017

M R Bassett

2

1 reference

27 August 2017

M Tsivian

3

1 reference

27 August 2017

L L Bañez

4

1 reference

27 August 2017

T J Polascik

5

1 reference

27 August 2017

M N Ferrandino

6

1 reference

27 August 2017

C N Robertson

7

1 reference

27 August 2017

S J Freedland

8

1 reference

27 August 2017

J W Moul

9

1 reference

27 August 2017

16 October 2012

1 reference

Prostate Cancer and Prostatic Diseases

27 August 2017

1 reference

27 August 2017

16

1 reference

27 August 2017

1

1 reference

27 August 2017

85-90

1 reference

https://scigraph.springernature.com/pub.10.1038/pcan.2012.38

27 August 2017

0 references

cites work

Active surveillance for the management of prostate cancer in a contemporary cohort

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

A multi-institutional evaluation of active surveillance for low risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Natural History of Early, Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Explaining racial differences in prostate cancer in the United States: sociology or biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Efficacy of brachytherapy for prostate cancer in African Americans compared with Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Differences in clinical characteristics and disease-free survival for Latino, African American, and non-Latino white men with localized prostate cancer: data from CaPSURE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Effect of socioeconomic factors on long-term mortality in men with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Impact of race on survival in patients with clinically nonmetastatic prostate cancer who deferred primary treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Racial differences in prostate androgen levels in men with clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Impact of race on biochemical disease recurrence after prostate brachytherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Effect of race and socioeconomic status on surgical margins and biochemical outcomes in an equal-access health care setting: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Methods of calculating prostate-specific antigen velocity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2012.38

31 March 2020

Identifiers

DOI

10.1038/PCAN.2012.38

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference